157 related articles for article (PubMed ID: 36485122)
1. Germline risk factors for second malignant neoplasms after treatment for pediatric hematologic malignancies.
Bhatia S
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):245-250. PubMed ID: 36485122
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.
Armstrong GT; Liu W; Leisenring W; Yasui Y; Hammond S; Bhatia S; Neglia JP; Stovall M; Srivastava D; Robison LL
J Clin Oncol; 2011 Aug; 29(22):3056-64. PubMed ID: 21709189
[TBL] [Abstract][Full Text] [Related]
3. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
4. Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors.
Lim H; Im M; Seo ES; Cho HW; Ju HY; Yoo KH; Cho SY; Kim JW; Lim DH; Sung KW; Lee JW
Cancer Res Treat; 2024 Apr; 56(2):642-651. PubMed ID: 37997325
[TBL] [Abstract][Full Text] [Related]
5. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
6. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience.
Broniscer A; Ke W; Fuller CE; Wu J; Gajjar A; Kun LE
Cancer; 2004 May; 100(10):2246-52. PubMed ID: 15139071
[TBL] [Abstract][Full Text] [Related]
7. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
8. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
9. Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.
Turcotte LM; Neglia JP; Reulen RC; Ronckers CM; van Leeuwen FE; Morton LM; Hodgson DC; Yasui Y; Oeffinger KC; Henderson TO
J Clin Oncol; 2018 Jul; 36(21):2145-2152. PubMed ID: 29874133
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas.
Uckunkaya O; Nöllke P; Hallmen E; Becker C; Stegmaier S; Sparber-Sauer M; Vokuhl C; Koscielniak E; Hettmer S
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e265-e270. PubMed ID: 32576783
[TBL] [Abstract][Full Text] [Related]
14. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
16. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
[TBL] [Abstract][Full Text] [Related]
18. Germline polymorphisms and the risk of therapy-related myeloid neoplasms.
Takahashi K
Best Pract Res Clin Haematol; 2019 Mar; 32(1):24-30. PubMed ID: 30927971
[TBL] [Abstract][Full Text] [Related]
19. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
20. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.
Bhatia S; Chen Y; Wong FL; Hageman L; Smith K; Korf B; Cannon A; Leidy DJ; Paz A; Andress JE; Friedman GK; Metrock K; Neglia JP; Arnold M; Turcotte LM; de Blank P; Leisenring W; Armstrong GT; Robison LL; Clapp DW; Shannon K; Nakamura JL; Fisher MJ
J Clin Oncol; 2019 Nov; 37(32):3050-3058. PubMed ID: 31532722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
